ArticleScientific reports2025
Pharmacokinetic and phytochemical screening of Allium subhirsutum leaves for antimicrobial and anti-inflammatory properties.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study aimed to screen the phytochemical composition of the leaves of Allium subhirsutum L. methanolic extract (ASE) by Gas Chromatography-Mass Spectrometry (GC-MS). Furthermore, the antioxidant, antibacterial and anti-inflammatory effects were examined using combined approaches: in silico, in vitro and in vivo on carrageenan-induced acute inflammation in rats. Inflammatory biomarkers (C-reactive protein and fibrinogen) oxidative injury parameters (thiobarbituric acid reactive substances, advanced oxidation of protein products, catalas, superoxide dismutase, and glutathione peroxidase) levels were assessed in the inflamed paws and compared to controls. The identified compounds in ASE possessed acceptable pharmacokinetic and ADMET (for absorption, distribution, metabolism, excretion and toxicity) properties. They bound the targeted receptors (Tyrosyl-tRNA synthetase and Gyrase of S. aureus, Human peroxiredoxin 5 and Cyclooxygenase-2) with acceptable affinities and established strong molecular interactions. ASE exhibited bacteriostatic and fungistatic action against different tested microbial strains. Moreover, histological examinations of paw edema revealed that ASE (given by gavage at 100 mg/kg BW for 10 days) ameliorate inflammation and oxidative stress status as outlined by anti-edematous, antioxidant and inflammatory biomarkers. Our investigation provided evidence that ASE could be useful in the management of oxidative stress, bacterial infections and acute inflammation. The results of the in silico assay supported these effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.